I

Ironwood Pharmaceuticals
D

IRWD

0.82390
USD
-0.01
(-0.79%)
مغلق
حجم التداول
12,725
الربح لكل سهم
1
العائد الربحي
-
P/E
-4
حجم السوق
133,323,373
أصول ذات صلة
ALNY
ALNY
1.29
(0.39%)
329.01 USD
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
C
CRBP
0.18000
(2.00%)
9.17000 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
NVS
NVS
0.260
(0.22%)
117.680 USD
S
SGMO
-0.01190
(-1.99%)
0.58600 USD
المزيد
الأخبار المقالات

العنوان: Ironwood Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses,commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.